This track focuses on transforming fragmented data into actionable insights through advanced visualization and analytics, ensuring clarity for strategic decision-making. It also explores how Generative AI and Large Language Models are reshaping competitive intelligence in pharma—unlocking new opportunities while raising critical questions around compliance, reliability, and organizational readiness.